Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma

1 Mar 2021

Abstract excerpt

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common pathology subtype of lung cancer. In recent years, immunotherapy, targeted therapy and chemotherapeutics conferred a certain curative effects. However, the effect and prognosis of LUAD patients are different, and the efficacy of existing LUAD risk prediction models is unsatisfactory. METHODS: The Cancer Genome Atlas (TCGA) LUAD dataset was downloaded. The...

Topics

Join the communities discussing this publication.

Bioinformatics and Genomic Networks
Cancer Immunotherapy and Biomarkers
Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33648465
DOI: 10.1186/s12885-021-07911-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinomaPMID 33648465Read ↗

Development of a Prognostic Model Based on Differentially Expressed Immune Genes of Lung AdenocarcinomaSemantic proximity Read ↗

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity Read ↗

An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity Read ↗

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaSemantic proximity Read ↗

Development and validation of an immune‐related prognostic signature in lung adenocarcinomaSemantic proximity Read ↗

Individualized Prognostic Score for Lung Adenocarcinoma Based on Immune StatusSemantic proximity Read ↗

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosisSemantic proximity Read ↗

Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genesSemantic proximity Read ↗

Prognostic value of immune related genes in lung adenocarcinomaSemantic proximity Read ↗

Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinomaSemantic proximity Read ↗

Identification and Validation of a Novel Prognostic Model of Inflammation-related Gene Signature of Lung AdenocarcinomaSemantic proximity Read ↗

Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.